Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy

[1]  R. Krüger,et al.  A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network , 2013, Journal of Medical Genetics.

[2]  K. Lohmann,et al.  A novel OPA3 mutation revealed by exome sequencing: an example of reverse phenotyping. , 2013, JAMA neurology.

[3]  R. Greenspan,et al.  Neurogenetics , 2019, Journal of the Neurological Sciences.

[4]  M. Durán,et al.  Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature , 2013, Journal of Inherited Metabolic Disease.

[5]  N. Newman,et al.  Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. , 2011, Ophthalmology.

[6]  P. Chinnery,et al.  Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies , 2011, Progress in Retinal and Eye Research.

[7]  Robert W. Taylor,et al.  The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. , 2010, Ophthalmology.

[8]  W. Gahl,et al.  OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. , 2010, Molecular genetics and metabolism.

[9]  Chulhee Choi,et al.  Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation , 2010, Cellular and Molecular Life Sciences.

[10]  J. Christodoulou,et al.  Costeff optic atrophy syndrome: New clinical case and novel molecular findings , 2008, Journal of Inherited Metabolic Disease.

[11]  M. Votruba.  Molecular genetic basis of primary inherited optic neuropathies , 2004, Eye.

[12]  P. Calvas,et al.  OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract , 2004, Journal of Medical Genetics.

[13]  W. Gahl,et al.  3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. , 2002, Molecular genetics and metabolism.

[14]  W. Gahl,et al.  Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. , 2001, American journal of human genetics.

[15]  N. Gadoth,et al.  A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia , 1989, Neurology.